Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2088013
Max Phase: Preclinical
Molecular Formula: C13H9BrClNO2
Molecular Weight: 326.58
Molecule Type: Small molecule
Associated Items:
ID: ALA2088013
Max Phase: Preclinical
Molecular Formula: C13H9BrClNO2
Molecular Weight: 326.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccc(Br)cc1)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C13H9BrClNO2/c14-8-1-4-10(5-2-8)16-13(18)11-7-9(15)3-6-12(11)17/h1-7,17H,(H,16,18)
Standard InChI Key: RLACRPKMRNEAIU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 326.58 | Molecular Weight (Monoisotopic): 324.9505 | AlogP: 4.06 | #Rotatable Bonds: 2 |
Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.39 | CX Basic pKa: | CX LogP: 4.13 | CX LogD: 3.83 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.87 | Np Likeness Score: -1.43 |
1. Kozic J, Novotná E, Volková M, Stolaříková J, Trejtnar F, Vinšová J.. (2012) Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues., 56 [PMID:22907036] [10.1016/j.ejmech.2012.07.044] |
2. Pauk K, Zadražilová I, Imramovský A, Vinšová J, Pokorná M, Masaříková M, Cížek A, Jampílek J.. (2013) New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species., 21 (21): [PMID:24045008] [10.1016/j.bmc.2013.08.029] |
3. Krátký M, Volková M, Novotná E, Trejtnar F, Stolaříková J, Vinšová J.. (2014) Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates., 22 (15): [PMID:24953953] [10.1016/j.bmc.2014.05.064] |
4. Paraskevopoulos G, Monteiro S, Vosátka R, Krátký M, Navrátilová L, Trejtnar F, Stolaříková J, Vinšová J.. (2017) Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity., 25 (4): [PMID:28126437] [10.1016/j.bmc.2017.01.016] |
Source(1):